Deep infection of infrapopliteal autogenous vein grafts—Immediate use of muscle flaps in leg salvage

AbstractPurpose: The purpose of this study was to determine the efficacy of an aggressive management of infrapopliteal autogenous vein graft infection. Methods: Among 341 consecutive infrapopliteal autogenous vein bypass grafts performed at the Helsinki University Central Hospital, 14 patients (4%) had infragenicular wound infection that involved the vein graft. Six of these patients had graft rupture and bleeding. An extensive débridement was performed in all patients. Seven of the grafts had to be partially removed and replaced. The wound and the graft immediately were covered with local muscle flaps in 4 patients and with free muscle flaps in 10 patients. Results: One patient died, and another patient underwent above-knee amputation as a result of a persistent infection and necrosis of the local muscle flap during the 30-day postoperative period. No graft rupture occurred after the treatment of the infected conduit. Graft occlusion occurred in 4 patients who underwent regrafting because of graft rupture and in 1 patient with an infected intact conduit. One patient underwent amputation 15 months later because of an uncontrollable infection despite a patent graft and a functioning flap. At the 1-month, 6-month, 1-year, and 2-year follow-up periods, the leg salvage rates were 92%, 75%, 55%, and 44%, respectively. At the same intervals, 92%, 92%, 70%, and 70% of the patients survived and 85%, 68%, 34%, and 34% of the patients were alive without the loss of their legs. Conclusion: Radical surgical débridement and immediate muscle flap coverage seem to offer an effective alternative method to preserve an infected infrapopliteal autogenous vein graft and to achieve leg salvage. Poor results are expected when a regrafting procedure is necessary for the rupture of an infected vein graft. (J Vasc Surg 1998;28:611-6.

Glycated Hemoglobin and the Risk of Sternal Wound Infection After Adult Cardiac Surgery: A Systematic Review and Meta-Analysis

Increased glycated hemoglobin (HbA1c) has been shown to increase the riskof mortality, myocardial infarction, and stroke after cardiac surgery, whereasits impact on the development of sternal wound infection (SWI) is less clear.A systematic review and meta-analysis were performed to evaluate theimpact of preoperative HbA1c levels on the occurrence of SWI after adultcardiac surgery. Fourteen studies including 17,609 patients fulfilled theinclusion criteria and were included in this analysis. Diagnostic test meta-analysis of studies evaluating baseline HbA1c cut-off values ranging from6% to 7% DCCT units (4253 mmol/mol IFCC units) showed that the diag-nostic odds ratio for deep SWI was 3.02 (95% confidence interval [CI]2.104.35), while the diagnostic odds ratio for any SWI was 2.81 (95% CI2.023.93). Binary meta-analysis confirmed that baseline HbA1c cut-off val-ues ranging from 6% to 7% increased the risk for deep SWI (pooled inci-dence 2.7% vs 0.8%, risk ratio [RR] 3.01, 95% CI 2.323.90,I20%). Sixstudies included only diabetics and their pooled RR for deep SWI was 2.94(1.595.45,I20%). Nine studies evaluated an HbA1c cut-off value of 7%and their RR for deep SWI was 3.22 (95% CI 2.384.37,I20%). The RR forany SWI was 2.92 (95% CI 2.423.53,I20%). This pooled analysis showedthat the risk of SWI is substantially increased when preoperative HbA1c lev-els are over 67%. Future studies should evaluate whether postponing sur-gery for optimization of the glycemic control can reduce the risk of SWI inpatients with increased levels of HbA1c.Semin Thoracic Surg&&:&&&&© 2019 Elsevier Inc. All rightsreserved.Keywords:Glycated hemoglobin, Glycosylated hemoglobin, HbA1c,Sternal wound infection, Cardiac surgery, Coronary artery bypass grafting</p

Competing Risk Analysis of the Impact of Pedal Arch Status and Angiosome-Targeted Revascularization in Chronic Limb-Threatening Ischemia

Introduction In the context of chronic limb threatening ischemia (CLTI), the prognostic impact of angiosome-targeted revascularization and of the status of the pedal arch are debated. Materials and method This series includes 580 patients who underwent endovascular (n=407) and surgical revascularization (n=173) of the infrapopliteal arteries for CLTI associated with foot ulcer or gangrene. The risk of major amputation after infrapopliteal revascularization was assessed by a competing risk approach. A subanalysis was made separately for patients who underwent endovascular or open surgical revascualrization. Results At 2 years, survival was 65.1% and leg salvage was 76.1%. Multivariable competing risk analysis showed that C-reactive protein≥ 10 mg/dL, diabetes, rheumatoid arthritis, increased number of affected angiosomes and the incomplete or total absence of pedal arch compared to complete pedal arch were independent predictors of major amputation after infrapopliteal revascularization. Multivariable analysis showed increasing risk estimates of major amputation in patients with incomplete (SHR 2.131, 95%CI 1.282-3.543) and no visualized pedal arch (SHR 3.022, 95%CI 1.553-5.883) compared to complete pedal arch. Pedal arch was important even if angiosome-targeted revascularization was achieved: Angiosome-directed revascularization in presence of complete pedal arch had a lower risk of major amputation (adjusted SHR 0.463, 95%CI 0.240-0.894) compared to angiosome-directed revascularization without complete pedal arch. In the subanalysis, among patients who underwent endovascular revascularization, complete pedal arch (SHR 0.509, 95%CI 0.286-0.905) and angiosome-targeted revascularization (SHR 0.613, 95%CI 0.394-0.956) were associated with a lower risk of major amputation. Conclusions Competing risk analysis showed that a patent pedal arch had significant impact on leg salvage and that the subset of patients undergoing endovascular procedure may most benefit of an angiosome-targeted revascularization.Peer reviewe

Computational fluid dynamics of a novel perfusion strategy using direct perfusion of a left carotid-subclavian bypass during hybrid thoracic aortic repair

To mitigate the risk of perioperative neurological complications during frozen elephant trunk procedures, we aimed to computationally evaluate the effects of direct cerebral perfusion strategy through a left carotid-subclavian bypass on hemodynamics in a patient-specific thoracic aorta model

13-year single-center experience with the treatment of acute type B aortic dissection

Background. Acute type B aortic dissection (TBAD) is catastrophic event associated with significant mortality and lifelong morbidity. The optimal treatment strategy of TBAD is still controversial. Methods. This analysis includes patients treated for TBAD at the Helsinki University Hospital, Finland in 2007-2019. The endpoints were early and late mortality, and intervention of the aorta. Results. There were 205 consecutive TBAD patients, 59 complicated and 146 uncomplicated patients (mean age of 66 +/- 14, females 27.8%). In-hospital and 30-day mortality rates were higher in complicated patients compared with uncomplicated patients with a statistically significant difference (p = 0.035 and p = 0.015, respectively). After a mean follow-up of 4.9 +/- 3.8 years, 36 (25.0%) and 22 (37.9%) TBAD -related adverse events occurred in the uncomplicated and complicated groups, respectively (p = 0.066). Freedom from composite outcome was 83 +/- 3% and 69 +/- 6% at 1 year, 75 +/- 4% and 63 +/- 7% at 5 years, 70 +/- 5% and 59 +/- 7% at 10 years in the uncomplicated group and in the complicated group, respectively (p = 0.052). There were 25 (39.1%) TBAD-related deaths in the overall series and prior aortic aneurysm was the only risk factor for adverse aortic-related events in multivariate analysis (HR 3.46, 95% CI 1.72-6.96, p < 0.001). Conclusion. TBAD is associated with a significant risk of early and late adverse events. Such a risk tends to be lower among patients with uncomplicated dissection, still one fourth of them experience TBAD-related event. Recognition of risk factors in the uncomplicated group who may benefit from early aortic repair would be beneficial.Peer reviewe

Mid-term outcomes of an alternative remodelling technique for aortic root replacement without coronary ostial mobilisation or reimplantation

BackgroundWe compare the early and late outcomes of a modified aortic root remodelling (ARR) technique for aortic root replacement without mobilisation or reimplantation of the coronary ostia, with those of the modified Bentall-de Bono procedure.MethodsA retrospective observational study was performed comprising 181 consecutive patients who underwent aortic root replacement with a modified Bentall-de Bono procedure (104 patients) or ARR (77 patients) between January 2013 and December 2019. Primary endpoints included hospital mortality and late survival. Secondary endpoints included incidence of post-operative complications and freedom from late re-operation.ResultsARR procedures were performed with shorter cross-clamp times and comparable cardiopulmonary bypass times to modified Bentall-de Bono procedures. The incidence of early post-complications was comparable between groups. 30-day mortality was numerically lower with ARR than the modified Bentall-de Bono procedure. Over 7-year follow-up, 4 patients (3.8%) required repeat aortic surgery after a modified Bentall-de Bono procedure, and none after ARR. Long-term mortality after ARR and after modified Bentall-de Bono procedures was 17.1% and 22.7%, respectively. The cumulative incidence of reintervention on the aortic root/valve was 3.2% after a modified Bentall-de Bono procedure and 0% after ARR. When adjusted for other independent risk factors, late mortality was not influenced by the procedure performed, although competing risk adjusted for age showed that the modified Bentall-de Bono procedure was associated with an increased risk of aortic root/aortic valve re-operation.ConclusionsThe modified ARR technique is associated with reduced myocardial ischaemia time, lower post-operative mortality and aortic re-intervention rates compared to a modified Bentall-de Bono procedure. It may be considered a safe and feasible procedure for aortic root/ascending aortic replacement offering good long-term outcomes.Peer reviewe

Early and mid-term outcome of patients with low-flow-low-gradient aortic stenosis treated with newer-generation transcatheter aortic valves

Peer reviewe

Central versus Peripheral Postcardiotomy Veno-Arterial Extracorporeal Membrane Oxygenation: Systematic Review and Individual Patient Data Meta-Analysis

Background: It is unclear whether peripheral arterial cannulation is superior to central arterial cannulation for postcardiotomy veno-arterial extracorporeal membrane oxygenation (VA-ECMO). Methods: A systematic review was conducted using PubMed, Scopus, and Google Scholar to identify studies on postcardiotomy VA-ECMO for the present individual patient data (IPD) meta-analysis. Analysis was performed according to the intention-to-treat principle. Results: The investigators of 10 studies agreed to participate in the present IPD meta-analysis. Overall, 1269 patients were included in the analysis. Crude rates of in-hospital mortality after central versus peripheral arterial cannulation for VA-ECMO were 70.7% vs. 63.7%, respectively (adjusted OR 1.38, 95% CI 1.08–1.75). Propensity score matching yielded 538 pairs of patients with balanced baseline characteristics and operative variables. Among these matched cohorts, central arterial cannulation VA-ECMO was associated with significantly higher in-hospital mortality compared to peripheral arterial cannulation VA-ECMO (64.5% vs. 70.8%, p = 0.027). These findings were confirmed by aggregate data meta-analysis, which showed that central arterial cannulation was associated with an increased risk of in-hospital mortality compared to peripheral arterial cannulation (OR 1.35, 95% CI 1.04–1.76, I2 21%). Conclusions: Among patients requiring postcardiotomy VA-ECMO, central arterial cannulation was associated with an increased risk of in-hospital mortality compared to peripheral arterial cannulation. This increased risk is of limited magnitude, and further studies are needed to confirm the present findings and to identify the mechanisms underlying the potential beneficial effects of peripheral VA-ECMO